CoChat
Sign Up
Cited by 755

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States

Chalasani, Naga, Fontana, Robert J., Bonkovsky, Herbert L., Watkins, Paul B., Davern, Timothy, Serrano, Jose, Yang, Hongqiu, Rochon, James·2008·Gastroenterology
DOI 10.1053/j.gastro.2008.09.011PMC PMC3654244
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2008.09.011

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Females have been reported to have increased, unchanged, or even decreased incidence of DILI.

    “females have been reported to have increased, 8,26,27,31 unchanged, 9,30 or even decreased 12,21 incidence of DILI (Table 4).”

    From Incidence and Etiology of Drug-Induced Liver Injury in Mainland China (2019) · cites this paper as [27]

  • Females are suggested to have a higher risk of idiosyncratic DILI than males in many retrospective studies.

    “Though females are suggested to have a higher risk of idiosyncratic DILI than males in many retrospective studies, 8,[27][28][29][30]”

    From Incidence and Etiology of Drug-Induced Liver Injury in Mainland China (2019) · cites this paper as [27]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 35

  1. Watkins, 2006, Drug-induced liver injury: summary of a single topic clinical research conference, Hepatology, 43, 618, 10.1002/hep.21095 · DOI
  2. Navarro, 2006, Drug-related hepatotoxicity, N Engl J Med, 35, 731, 10.1056/NEJMra052270 · DOI · Paper page
  3. Abboud, 2007, Drug-induced liver injury, Drug Saf, 30, 277, 10.2165/00002018-200730040-00001 · DOI
  4. Ostapowicz, 2002, Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States, Ann Intern Med, 137, 947, 10.7326/0003-4819-137-12-200212170-00007 · DOI · Paper page
  5. Uetrecht, 2007, Idiosyncratic drug reactions: current understanding, Annu Rev Pharmacol Toxicol, 47, 513, 10.1146/annurev.pharmtox.47.120505.105150 · DOI
  6. Wilkes, 2007, Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges, Nat Rev Drug Discov, 6, 904, 10.1038/nrd2423 · DOI
  7. Lammert, 2008, Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals, Hepatology, 47, 2003, 10.1002/hep.22272 · DOI
  8. Senior, 2008, What is idiosyncratic hepatotoxicity?, Hepatology, 47, 1813, 10.1002/hep.22332 · DOI
  9. Seeff, 2007, Herbal hepatotoxicity, Clin Liver Dis, 11, 577, 10.1016/j.cld.2007.06.005 · DOI
  10. Elinav, 2007, Association between consumption of Herbalife® nutritional supplements and acute hepatotoxicity, J Hepatol, 47, 514, 10.1016/j.jhep.2007.06.016 · DOI
  11. Schoepfer, 2007, Herbal does not mean innocuous: ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife® products, J Hepatol, 47, 521, 10.1016/j.jhep.2007.06.014 · DOI
  12. Sarma, 2008, Safety of green tea extracts: a systematic review by the US Pharmacopeia, Drug Saf, 31, 469, 10.2165/00002018-200831060-00003 · DOI
  13. Bonkovsky, 2006, Hepatotoxicity associated with supplements containing Chinese Green Tea (Camellia sinensis), Ann Intern Med, 144, 68, 10.7326/0003-4819-144-1-200601030-00020 · DOI
  14. Gardiner, 2007, Factors associated with herbal therapy use by adults in the United States, Altern Ther Health Med, 13, 22
  15. Uetrecht, 2008, Idiosyncratic drug reactions: past, present, and future, Chem Res Toxicol, 21, 84, 10.1021/tx700186p · DOI
  16. Ingelman-Sundberg, 2008, Pharmacogenomic biomarkers for prediction of severe adverse drug reactions, N Engl J Med, 358, 637, 10.1056/NEJMe0708842 · DOI
  17. Eichelbaum, 2006, Pharmacogenomics and individualized drug therapy, Annu Rev Med, 57, 119, 10.1146/annurev.med.56.082103.104724 · DOI
  18. Hoofnagle, 2004, Drug-Induced Liver Injury Network (DILIN), Hepatology, 40, 773, 10.1002/hep.20445 · DOI
  19. Fontana RJ, Watkins PB, Bonkovsky HL, et al. Rationale, design and conduct of the Drug-Induced Liver Injury Network (DILIN) prospective study. Drug Saf (in press).
  20. Rockey, 2007, Comparison between expert opinion and RUCAM for assignment of causality in drug induced liver injury, Gastroenterology, 132, A-773
  21. Benichou, 1990, Criteria of drug induced liver disorders: report of an international consensus meeting, J Hepatol, 11, 272, 10.1016/0168-8278(90)90124-A · DOI · Paper page
  22. Danan, 1993, Causality assessment of adverse reactions to drugs - I, J Clin Epidemiol, 46, 1323, 10.1016/0895-4356(93)90101-6 · DOI · Paper page
  23. Benichou, 1993, Causality assessment of adverse reactions to drugs–II, J Clin Epidemiol, 46, 1331, 10.1016/0895-4356(93)90102-7 · DOI · Paper page
  24. Andrade, 2005, Drug induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period, Gastroenterology, 129, 512, 10.1016/j.gastro.2005.05.006 · DOI · Paper page
  25. De Valle, 2006, Drug induced liver injury in a Swedish University Hospital out-patient hepatology clinic, Aliment Pharmacol Ther, 24, 1187, 10.1111/j.1365-2036.2006.03117.x · DOI · Paper page
  26. Pillans, 1996, Drug associated hepatic reactions in New Zealand: 21 years experience, N Z Med J, 109, 315
  27. Björnsson, 2005, Outcome and prognostic markers in severe drug-induced liver disease, Hepatology, 42, 481, 10.1002/hep.20800 · DOI · Paper page
  28. Ganey, 2004, Adverse hepatic drug reactions: inflammatory episodes as consequence and contributor, Chem Biol Interact, 150, 35, 10.1016/j.cbi.2004.09.002 · DOI
  29. Dalton, 2007, The role of hepatitis E virus testing in drug-induced liver injury, Aliment Pharmacol Ther, 26, 1429, 10.1111/j.1365-2036.2007.03504.x · DOI
  30. El-Serag, 2002, Diabetes increases the risk of acute hepatic failure, Gastroenterology, 122, 1822, 10.1053/gast.2002.33650 · DOI
  31. Wang, 2007, Mechanisms and outcomes of drug-and toxicant-induced liver toxicity in diabetes, Clin Rev Toxicol, 37, 413, 10.1080/10408440701215100 · DOI
  32. Björnsson, 2007, The impact of eosinophilia and hepatic necrosis on prognosis in patients with drug-induced liver injury, Aliment Pharmcol Ther, 25, 1411, 10.1111/j.1365-2036.2007.03330.x · DOI
  33. Ohmori, 2003, Clinical characteristics and prognostic indicators of drug-induced fulminant hepatic failure, Hepatogastroenterology, 50, 1531
  34. Björnsson, 2006, Drug-induced liver injury: Hy's rule revisited, Clin Pharmacol Ther, 79, 521, 10.1016/j.clpt.2006.02.012 · DOI
  35. Sgro, 2002, Incidence of drug-induced hepatic injuries: a French population-based study, Hepatology, 36, 451, 10.1053/jhep.2002.34857 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Chalasani, N., Fontana, R. J., Bonkovsky, H. L., Watkins, P. B., Davern, T., Serrano, J., Yang, H., & Rochon, J.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2008-12
Volume
135
Issue
6
Pages
1924-1934.e4
ISSN
0016-5085
DOI
10.1053/j.gastro.2008.09.011
PMC
PMC3654244
Cited by
755
References
1
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review